Stabilization of pharmaceutical protein formulations with small peptides
    1.
    发明授权
    Stabilization of pharmaceutical protein formulations with small peptides 失效
    用小肽稳定药物蛋白质制剂

    公开(公告)号:US07141544B2

    公开(公告)日:2006-11-28

    申请号:US10683549

    申请日:2003-10-10

    IPC分类号: A61K38/22

    摘要: The present invention relates to stable pharmaceutical protein formulations that are stabilized using peptide stabilizers selected from the group consisting of Gly-Gly, Gly-Gly-Gly, Gly-Tyr, Gly-Phe, Gly-His, Gly-Asp, Gly-Ala, Ala-Gly, Ala-Ala, derivatives thereof and mixtures thereof. Furthermore, the present invention relates to stable pharmaceutical formulations comprising erythropoietin and peptide stabilizers selected from dipeptides, tripeptides, tetrapeptides, pentapeptides, and mixtures thereof. In addition to peptide stabilizers, the formulations may contain surfactants.

    摘要翻译: 本发明涉及稳定的药物蛋白质制剂,其使用选自Gly-Gly,Gly-Gly-Gly,Gly-Tyr,Gly-Phe,Gly-His,Gly-Asp,Gly-Ala ,Ala-Gly,Ala-Ala,其衍生物及其混合物。 此外,本发明涉及包含促红细胞生成素和选自二肽,三肽,四肽,五肽及其混合物的肽稳定剂的稳定药物制剂。 除了肽稳定剂之外,制剂可以含有表面活性剂。

    Stabilization of pharmaceutical protein formulations with small peptides
    2.
    发明申请
    Stabilization of pharmaceutical protein formulations with small peptides 失效
    用小肽稳定药物蛋白质制剂

    公开(公告)号:US20050080011A1

    公开(公告)日:2005-04-14

    申请号:US10683549

    申请日:2003-10-10

    摘要: The present invention relates to stable pharmaceutical protein formulations that are stabilized using peptide stabilizers selected from the group consisting of Gly-Gly, Gly-Gly-Gly, Gly-Tyr, Gly-Phe, Gly-His, Gly-Asp, Gly-Ala, Ala-Gly, Ala-Ala, derivatives thereof and mixtures thereof. Furthermore, the present invention relates to stable pharmaceutical formulations comprising erythropoietin and peptide stabilizers selected from dipeptides, tripeptides, tetrapeptides, pentapeptides, and mixtures thereof. In addition to peptide stabilizers, the formulations may contain surfactants.

    摘要翻译: 本发明涉及稳定的药物蛋白质制剂,其使用选自Gly-Gly,Gly-Gly-Gly,Gly-Tyr,Gly-Phe,Gly-His,Gly-Asp,Gly-Ala ,Ala-Gly,Ala-Ala,其衍生物及其混合物。 此外,本发明涉及包含促红细胞生成素和选自二肽,三肽,四肽,五肽及其混合物的肽稳定剂的稳定药物制剂。 除了肽稳定剂之外,制剂可以含有表面活性剂。

    BICARBONATE-BASED PERITONEAL DIALYSIS SOLUTIONS
    7.
    发明申请
    BICARBONATE-BASED PERITONEAL DIALYSIS SOLUTIONS 审中-公开
    基于二氧化碳的透析解决方案

    公开(公告)号:US20060226080A1

    公开(公告)日:2006-10-12

    申请号:US11425911

    申请日:2006-06-22

    IPC分类号: B01D11/00

    摘要: Dialysis solutions and methods of manufacturing and using same are provided. The dialysis solution at least includes three solution parts that are separately stored and sterilized at an effective pH to promote the stabilization of the solution parts including a pH-sensitive solution part that has, for example, a pH-sensitive osmotic agent, such as a glucose polymer. The solution parts are admixed to form a ready-to-use solution with a physiologically acceptable pH.

    摘要翻译: 提供了透析溶液及其制造和使用方法。 所述透析溶液至少包括三个溶液部分,其在有效pH下分开存储和灭菌,以促进溶液部分的稳定化,包括pH敏感溶液部分,其具有例如pH敏感性渗透剂,例如 葡萄糖聚合物。 将溶液部分混合以形成具有生理上可接受的pH的即用型溶液。